U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1052

1.

Study of microbial species in extracellular vesicles of sclerosis multiple patients

(Submitter supplied) Extracellular vesicles (EVs) are released by most cell types and are implicated in several biological and pathological processes, including multiple sclerosis (MS). In this study we performed RNA sequencing to analyze the diversity of microorganisms by assignment of reads using different taxa profilers. To diminish the risk of false positive biases derived from sample handling, we performed a similar analysis on EVs derived from known cultured bacterial species, as well as artificially-generated samples. more...
Organism:
Lactobacillus acidophilus; Homo sapiens; synthetic construct; Bifidobacterium animalis subsp. lactis
Type:
Expression profiling by high throughput sequencing
4 related Platforms
15 Samples
Download data: CSV
Series
Accession:
GSE255317
ID:
200255317
2.

A cell-free pipeline for recreating methylation patterns radically enhances DNA transformation in bacteria

(Submitter supplied) The bacterial world offers diverse strains for understanding medical and environmental processes and for engineering synthetic-biology chasses. However, genetically manipulating these strains has faced a long-standing bottleneck: how to efficiently transform DNA. Here we report IMPRINT, a generalized, rapid and scalable approach to overcome DNA restriction, a prominent barrier to transformation. IMPRINT utilizes cell-free systems to express DNA methyltransferases from the bacterial host’s restriction-modification systems. more...
Organism:
Escherichia coli; Bifidobacterium breve
Type:
Other
Platforms:
GPL25368 GPL33564
7 Samples
Download data: TSV
Series
Accession:
GSE240651
ID:
200240651
3.

A cell-free pipeline for recreating methylation patterns radically enhances DNA transformation in bacteria

(Submitter supplied) We report a method for bypassing restriction modification systems to increase DNA transformation in batceria and develop a high-throughput way to determine the optimal methylation pattern for DNA transformation.
Organism:
Bifidobacterium breve
Type:
Other
Platform:
GPL31014
8 Samples
Download data: XLSX
Series
Accession:
GSE189864
ID:
200189864
4.

Bifidobacterium infantis intracellular 2-oxogluturate concentration is inversely related to nitrogen accessibility

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) resides in the human infant gut and helps with the utilization of human milk-derived nutrient components. While its utilization of various carbohydrate sources has been studied extensively, mechanisms behind utilization of nitrogen components from human milk remain largely unknown. In this study, we present B. infantis growth profiles on the N-containing human milk oligosaccharides (HMO) as nitrogen sources, namely, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
14 Samples
Download data: CSV, TXT
Series
Accession:
GSE209665
ID:
200209665
5.

Gene expression in B breve SW1107E in the presence of media containing lactose, BMO and 3SL as carbon sources

(Submitter supplied) Bifidobacterium species in the infant gut can metabolize intact human milk oligosaccrides. There is species varation in the types of the olgosaccharides that can bedigested by Bifidobacterium species. B. breve strains have shown digestion of LNT and LNnT oligoscchrides. The objective of te current study was idetification of B. breve strains that can digest sialylated oligosacchrides. The currnet study was designed to idetify the genes that show upregulation when grown in lactose, 3'-siallylactose and Bovine Milk Oligosaccharides
Organism:
Bifidobacterium breve
Type:
Expression profiling by high throughput sequencing
Platform:
GPL33564
9 Samples
Download data: TXT
Series
Accession:
GSE237076
ID:
200237076
6.

Transcriptome analysis of Bifidobacterium adolescentis P2P3 cultivated with resistant starch

(Submitter supplied) RNA-seq based transcriptome analysis was employed to understand the genome-wide expression patterns under cultivation with resistant starch (RS). To identify differentially expressed genes, we compared RS-induced transcriptome to non-RS transcriptome as sole carbon source.
Organism:
Bifidobacterium adolescentis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL27584
8 Samples
Download data: TXT
Series
Accession:
GSE138588
ID:
200138588
7.

Bifidobacterium longum subsp. infantis transcriptomes in response to various nitrogen sources

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. infantis to human milk urea compared to complex nitrogen and L-cysteine.
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
18 Samples
Download data: TXT
Series
Accession:
GSE155078
ID:
200155078
8.

Copra β-mannooligosaccharide utilization by Bifidobacterium adolescentis ATCC 15703

(Submitter supplied) In order to understand gene expression profile of Bifidobacterium adolescentis ATCC 15703, it was grown in minimal media upto late log phase in the presence of β-mannooligosaccharide from copra till OD A600 = 0.800
Organism:
Bifidobacterium adolescentis; Bifidobacterium adolescentis ATCC 15703
Type:
Expression profiling by array
Platform:
GPL30400
8 Samples
Download data: TXT
Series
Accession:
GSE180349
ID:
200180349
9.

Human Milk Oligosaccharide Utilization in Intestinal Bifidobacteria is Governed by Global Transcriptional Regulator NagR

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) is a prevalent beneficial bacterium that colonizes the human neonatal gut and is uniquely adapted to efficiently use human milk oligosaccharides (HMOs) as a carbon and energy source. Multiple studies have focused on characterizing the elements of HMO utilization machinery in B. infantis; however, the regulatory mechanisms governing the expression of these catabolic pathways remain poorly understood. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
12 Samples
Download data: TXT
Series
Accession:
GSE196064
ID:
200196064
10.

Growth phase-associated changes in the proteome and transcriptome of Bifidobacterium animalis subsp. lactis A6

(Submitter supplied) This study was aimed to further illustrate the expression files of BAA6 between the stationary phase and the exponential phase in MRSc broth, we combined the transcriptomic analysis with RNA sequencing and tandem mass tags (TMT) quantitative proteomic methods to quantitatively screen the differentially expressed genes and proteins. During the stationary phase, BAA6 expanded its carbon source utilizing profile and enhanced the transport of cellobiose, xylooligosaccharides (XOS), and raffinose to confront with glucose consumption. more...
Organism:
Bifidobacterium animalis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL30086
7 Samples
Download data: XLS
Series
Accession:
GSE173957
ID:
200173957
11.

Effects of housekeeping sortase disruption on Bifidibacterium bifidum toranscriptome

(Submitter supplied) To explore the molecular mechanism of B. bifidum adhesion, we compared transcriptomes among WT and non-adhesive mutants cultured in MRS or m-ILS medium.
Organism:
Bifidobacterium bifidum
Type:
Expression profiling by array
Platform:
GPL30211
8 Samples
Download data: TXT
Series
Accession:
GSE175843
ID:
200175843
12.

RNA sequencing of Bifidobacterium pseudocatenulatum MP80 grown on Lactose 2'-FL and LNFP-1

(Submitter supplied) RNA sequencing revolutionized the bacterial gene expression analysis. The objective of this study was to identify the genes involved in metabolism of 2'-FL and LNFP1 in Bifidobacterium pseudocatenulatum MP80. We have obtained a list of genes upregulated in Bifidobacterium pseudocatenulatum MP80 when it is grown in 2% 2'-FL and LNFP1. Lactose grown samples were used as the control.
Organism:
Bifidobacterium pseudocatenulatum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL30210
12 Samples
Download data: TXT
Series
Accession:
GSE175820
ID:
200175820
13.

Analysis of EPS structure and transcriptome expression difference of Bifidobacterium longum W13 and W13R

(Submitter supplied) The purpose of this course is to study the relationship between the primary structure of exopolysaccharides and the gene expression level of Bifidobacterium longum W13 and W13R, and to better explain the differences between different strains from the level of gene transcription.
Organism:
Bifidobacterium longum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL29554
6 Samples
Download data: TXT
Series
Accession:
GSE164163
ID:
200164163
14.

Comprehensive genomic, phenotypic and transcriptomic approaches to enhance Bifidobacterium animalis subsp. animalis growth and survival in milk

(Submitter supplied) Bifidobacterium animalis subsp. animalis CNCM I-4602 was tested for its ability to grow in reconstituted skimmed milk (RSM). Strain CNCM I-4602 grows and survives poorly in reconstituted skimmed milk (RSM), although this was partially countered by the addition of certain compounds, including yeast extract, uric acid, glutathione, cysteine, ferrous sulfate and a combination of magnesium sulfate and manganese sulfate. more...
Organism:
Bifidobacterium animalis subsp. animalis; Bifidobacterium animalis
Type:
Expression profiling by array
Platform:
GPL24807
4 Samples
Download data: TXT
Series
Accession:
GSE112626
ID:
200112626
15.

Bifidobacterium longum subsp. infantis (B. infantis) strain dependent utilization of human milk oligosaccharides

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) colonizes the infant gut microbiome with a 43-kb gene cluster that enables human milk oligosaccharide (HMO) utilization. Although there is relative genomic homogeneity in this regard, previous observations suggest that B. infantis strains may differ in their utilization phenotype. To test this hypothesis, a panel of B. infantis strains were evaluated for their ability to utilize pooled HMOs to yield differential phenotypes including biomass accumulation, HMO consumption glycoprofile, end-product secretion, and global transcriptomes. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
32 Samples
Download data: DAT, FASTA, MATRIX
Series
Accession:
GSE164005
ID:
200164005
16.

Bifidobacterium infantis metabolizes 2´fucosyllactose-derived and free fucose through a common catabolic pathway resulting in 1,2-propanediol secretion

(Submitter supplied) Human milk oligosaccharides (HMOs) enrich beneficial bifidobacteria in the infant gut microbiome which produce molecules that impact development and physiology. 2´fucosyllactose (2´FL) is a highly abundant fucosylated HMO which is utilized by Bifidobacterium longum subsp. infantis, despite limited scientific understanding of the underlying mechanism. Moreover, there is not a current consensus on whether free fucose could be metabolized when not incorporated in a larger oligosaccharide structure. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
6 Samples
Download data: CSV, TXT
Series
Accession:
GSE159189
ID:
200159189
17.

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697

(Submitter supplied) Human milk oligosaccharides (HMOs) function as prebiotics for beneficial bacteria in the developing gut, often dominated by Bifidobacterium spp. To understand the relationship between Bifidobacterium utilizing HMOs and how the metabolites that are produced could affect the host, we analyzed the metabolism of HMO 2’-fucosyllactose (2’-FL), 3-fucosyllactose (3FL and difucosyllactose (DFL) in Bifidobacterium longum ssp. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL25787
41 Samples
Download data: TSV
Series
Accession:
GSE151933
ID:
200151933
18.

RNA-seq of Bifidobacterium longum NCC2705

(Submitter supplied) Bacterial promoters consist of core sequence motifs termed –35 and –10 boxes. The consensus motifs are TTGACA and TATAAT, respectively, which were identified from leading investigations on E. coli. However, the consensus sequences are not likely to fit genetically divergent bacteria. The sigma factor of the genus Bifidobacterium has a characteristic polar domain in the N-terminus, suggesting the possibility of specific promoter recognition. more...
Organism:
Bifidobacterium longum NCC2705
Type:
Expression profiling by high throughput sequencing
Platform:
GPL27983
3 Samples
Download data: XLSX
Series
Accession:
GSE143410
ID:
200143410
19.

Bifidobacterium kashiwanohense expresses fucosidases necessary for fucosyllactose utilisation as an adaptation to the infant gut environment

(Submitter supplied) Bifidobacteria dominate the composition of the neonatal gut microbiota in the first number of weeks following birth. A number of species in particular are found with a significantly higher frequency in the microbiome of breastfed infants, owing to their ability to rely on Human Milk Oligosacchraides (HMOs) as their sole carbohydrate substrate; namely B. bifidum, B. longum spp. infantis and B. breve. more...
Organism:
Bifidobacterium catenulatum subsp. kashiwanohense; Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platforms:
GPL24138 GPL24316
10 Samples
Download data: TXT
Series
Accession:
GSE107439
ID:
200107439
20.

Effect of linoleic acid on gut-derived Bifidobacterium breve DSM 20213: a transcriptomic approach

(Submitter supplied) we investigated the effect of linoleic acid on the metabolism Bifidobacterium breve DSM 20213 by means of transcriptomic approach
Organism:
Bifidobacterium breve DSM 20213 = JCM 1192
Type:
Expression profiling by high throughput sequencing
Platform:
GPL27650
6 Samples
Download data: TXT
Series
Accession:
GSE139284
ID:
200139284
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=txid31953[Organism:exp]|query=1|qty=406|blobid=MCID_665bb73bb6fda621991d7643|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center